CymaBay Therapeutics, Inc.

NORTHERN TRUST CORP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

1,090,087

Value ($000)

25,748

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	25,748	0.0%	1,090,087	12/31/2023
2023 Q3	11/13/2023	15,022	0.0%	1,007,512	9/30/2023
2023 Q2	8/11/2023	10,681	0.0%	975,399	6/30/2023
2023 Q1	5/15/2023	1,827	0.0%	209,477	3/31/2023
2022 Q4	2/13/2023	880	0.0%	140,279	12/31/2022
2022 Q3	11/14/2022	492	0.0%	140,509	9/30/2022
2022 Q2	8/12/2022	410	0.0%	138,989	6/30/2022
2022 Q1	5/13/2022	2,275	0.0%	731,717	3/31/2022
2021 Q4	2/8/2022	2,048	0.0%	606,077	12/31/2021
2021 Q3	11/15/2021	2,235	0.0%	612,482	9/30/2021
2021 Q2	8/13/2021	2,783	0.0%	638,226	6/30/2021
2021 Q1	5/12/2021	3,131	0.0%	689,634	3/31/2021
2020 Q4	2/11/2021	4,189	0.0%	729,721	12/31/2020
2020 Q3	11/16/2020	5,381	0.0%	743,171	9/30/2020
2020 Q2	8/14/2020	2,705	0.0%	775,144	6/30/2020
2020 Q1	5/14/2020	1,244	0.0%	840,907	3/31/2020
2019 Q4	2/14/2020	1,598	0.0%	815,190	12/31/2019